At a glance
ClinicalIndex Comparison RecordN/ACompleted· 292 enrolled
Drug / intervention
Consumer-facing wearable smart watchdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Study of the Role and Accuracy of Consumer-Facing Wearable Technology in Gastrointestinal Endoscopy
In Brief
A clinical study evaluating Consumer-facing wearable smart watch for Healthy. Completed, enrolled 292 participants across 1 site.
Detailed Summary
Researchers are assessing the accuracy and safety of wearable technology in subjects undergoing endoscopic gastrointestinal procedures with sedation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedSep 2021
Enrollment StartJan 2022
Primary CompletionSep 2022
TodayJul 2026
First PostedSep 14, 2021
Enrollment StartJan 11, 2022
Primary CompletionSep 1, 2022
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 4.8 years ago
Interventions
Consumer-facing wearable smart watchdevice
Wearable watch technology that has the ability to measure heart rate, respiratory rate, single-lead electrocardiography, and blood oxygen saturation.